181 related articles for article (PubMed ID: 28918838)
1. Inhibition of Midkine Suppresses Prostate Cancer CD133
Erdogan S; Doganlar ZB; Doganlar O; Turkekul K; Serttas R
Am J Med Sci; 2017 Sep; 354(3):299-309. PubMed ID: 28918838
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancer.
Hao H; Maeda Y; Fukazawa T; Yamatsuji T; Takaoka M; Bao XH; Matsuoka J; Okui T; Shimo T; Takigawa N; Tomono Y; Nakajima M; Fink-Baldauf IM; Nelson S; Seibel W; Papoian R; Whitsett JA; Naomoto Y
PLoS One; 2013; 8(8):e71093. PubMed ID: 23976985
[TBL] [Abstract][Full Text] [Related]
3. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
[TBL] [Abstract][Full Text] [Related]
4. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
[TBL] [Abstract][Full Text] [Related]
5. Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
Li K; Liu C; Zhou B; Bi L; Huang H; Lin T; Xu K
Int J Mol Sci; 2013 Jun; 14(6):11981-93. PubMed ID: 23739676
[TBL] [Abstract][Full Text] [Related]
6. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
Aghajani M; Mokhtarzadeh A; Aghebati-Maleki L; Mansoori B; Mohammadi A; Safaei S; Asadzadeh Z; Hajiasgharzadeh K; Khaze Shahgoli V; Baradaran B
Mol Biol Rep; 2020 May; 47(5):3691-3703. PubMed ID: 32246247
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response.
Yan J; Tang D
Exp Cell Res; 2014 Oct; 328(1):132-142. PubMed ID: 25149681
[TBL] [Abstract][Full Text] [Related]
8. The natural flavonoid apigenin sensitizes human CD44
Erdogan S; Turkekul K; Serttas R; Erdogan Z
Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
[TBL] [Abstract][Full Text] [Related]
9. Midkine positively regulates the proliferation of human gastric cancer cells.
Xu Y; Qu X; Zhang X; Luo Y; Zhang Y; Luo Y; Hou K; Liu Y
Cancer Lett; 2009 Jul; 279(2):137-44. PubMed ID: 19250738
[TBL] [Abstract][Full Text] [Related]
10. Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin.
Zhang Y; Jin Z; Zhou H; Ou X; Xu Y; Li H; Liu C; Li B
Cancer Med; 2016 Jun; 5(6):1251-8. PubMed ID: 26899963
[TBL] [Abstract][Full Text] [Related]
11. Eupatilin Inhibits the Proliferation and Migration of Prostate Cancer Cells through Modulation of PTEN and NF-κB Signaling.
Serttas R; Koroglu C; Erdogan S
Anticancer Agents Med Chem; 2021; 21(3):372-382. PubMed ID: 32781972
[TBL] [Abstract][Full Text] [Related]
12. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from
Kamalidehghan B; Ghafouri-Fard S; Motevaseli E; Ahmadipour F
Drug Des Devel Ther; 2018; 12():1119-1133. PubMed ID: 29765202
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
[TBL] [Abstract][Full Text] [Related]
16. Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells.
Mahajan NP; Coppola D; Kim J; Lawrence HR; Lawrence NJ; Mahajan K
Sci Rep; 2018 Jan; 8(1):1954. PubMed ID: 29386546
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
18. A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor.
Ishida N; Fukazawa T; Maeda Y; Yamatsuji T; Kato K; Matsumoto K; Shimo T; Takigawa N; Whitsett JA; Naomoto Y
Exp Cell Res; 2015 Jul; 335(2):197-206. PubMed ID: 25839409
[TBL] [Abstract][Full Text] [Related]
19. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
[TBL] [Abstract][Full Text] [Related]
20. Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer.
Shin DH; Jo JY; Kim SH; Choi M; Han C; Choi BK; Kim SS
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
